UR-144

Overview

UR-144 (TMCP-018, KM-X1, MN-001, YX-17) is a drug invented by Abbott Laboratories, that acts as a selective full agonist of the peripheral cannabinoid receptor CB₂, but with much lower affinity for the psychoactive CB₁ receptor.[1] WP

Pharmacology

Pharmacology

UR-144 has high affinity for the CB₂ receptor with a Kᵢ of 1.8 nM but 83x lower affinity for the CB₁ receptor with a Kᵢ of 150 nM. UR-144 was found to possess an EC₅₀ of 421 nM for human CB₁ receptors, and 72 nM for human CB₂ receptors. UR-144 produces bradycardia and hypothermia in rats at a dose of 10 mg/kg, suggesting weak cannabinoid-like activity.[2][3] WP

Chemically it is closely related to other 2,2,3,3-tetramethylcyclopropyl synthetic cannabinoids like A-796,260 and A-834,735 but with a different substitution on the 1-position of the indole core, in these compounds its 1-pentyl group is replaced with alkylheterocycles like 1-(2-morpholinoethyl) and 1-(tetrahydropyran-4-ylmethyl). WP

Detection

A forensic standard of UR-144 is available, and the compound has been posted on the Forendex website of potential drugs of abuse. An ELISA immunoassay technique for detecting UR-144 in urine as part of general drug screens has been developed by Tulip Biolabs, Inc. An Homogeneous Immunoassay that runs on most Clinical Chemistry Analyzers and detects several UR and XLR synthetic cannabinoids has been developed and introduced by Immunalysis Inc. Pomona USA.[4] WP

Legal status

Legality

The UK ACMD recommended that generic prohibition legislation be extended to include UR-144 in October 2012. The UK Home Office accepted the recommendation and enacted legislation to ban UR-144 as a class B drug along with a number of other drugs on February 26, 2013, as a part of The Misuse of Drugs Act 1971 (Amendment) Order 2013.[5] WP

UR-144 was detected in Korea, 2012. This molecule is very close to KM-X1, MN-001, YX-17 and Kr-11.[6] WP

UR-144 (Abbott patent) has been detected as an ingredient of synthetic cannabis smoking blends in New Zealand, and subsequently banned from sale as a temporary class drug on 6 April 2012. It has also been encountered in smoking blends and subsequently banned in Russia.[7][8] WP

As of October 2015 UR-144 is a controlled substance in China.[9] WP

UR-144 is banned in the Czech Republic.[10] WP

Chemistry

Formula

C21H29NO PC

CAS number

1199943-44-6 PC

Molar mass (g/mol)

311.5 PC

IUPAC name (computed by PubChem)

(1-pentylindol-3-yl)-(2,2,3,3-tetramethylcyclopropyl)methanone PC

SMILES

CCCCCN1C=C(C2=CC=CC=C21)C(=O)C3C(C3(C)C)(C)C PC

InChIKey

NBMMIBNZVQFQEO-UHFFFAOYSA-N PC

PubChem CID

44626619

IUPAC name

(1-pentylindol-3-yl)-(2,2,3,3-tetramethylcyclopropyl)methanone WP

Harm reduction information

No harm reduction data is on file for this compound yet. That means no dose, timing or combination data from PsychonautWiki or TripSit. Please don't guess a dose from similar compounds. If you have taken it and feel unwell, contact emergency services or a poison control center.

User reports

Pop culture

No references added yet.

Sources

1. Other 3-Cycloalkylcarbonyl indoles as cannabinoid receptor ligands
2. Journal / agency Frost JM, Dart MJ, Tietje KR, Garrison TR, Grayson GK, Daza AV, El-Kouhen OF, Yao BB, Hsieh GC, Pai M, Zhu CZ, Chandran P, Meyer MD. Indol-3-ylcycloalkyl ketones: effects of N1 substituted indole side chain variations on CB(2) cannabinoid receptor activity. Journal of Medicinal Chemistry. January 2010. doi:10.1021/jm901214q · PMID 19921781
3. Journal / agency Banister SD, Stuart J, Kevin RC, Edington A, Longworth M, Wilkinson SM, Beinat C, Buchanan AS, Hibbs DE, Glass M, Connor M, McGregor IS, Kassiou M. Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135. ACS Chemical Neuroscience. August 2015. doi:10.1021/acschemneuro.5b00107 · PMID 25921407
4. Other Southern Association of Forensic Scientists
5. Other Further consideration of the synthetic cannabinoids. 18 October 2012
6. Journal / agency Almada M, Alves P, Fonseca BM, Carvalho F, Queirós CR, Gaspar H, Amaral C, Teixeira NA, Correia-da-Silva G. Synthetic cannabinoids JWH-018, JWH-122, UR-144 and the phytocannabinoid THC activate apoptosis in placental cells. Toxicology Letters. February 2020. doi:10.1016/j.toxlet.2019.11.004 · PMID 31730886
7. Other Temporary Class Drug Notices. New Zealand Ministry of Health
8. Journal / agency Sobolevsky T, Prasolov I, Rodchenkov G. Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids. Drug Testing and Analysis. October 2012. doi:10.1002/dta.1418 · PMID 23042760
9. Journal / agency 关于印发《非药用类麻醉药品和精神药品列管办法》的通知. 27 September 2015
10. Other Látky, o které byl doplněn seznam č. 4 psychotropních látek (příloha č. 4 k nařízení vlády č. 463/2013 Sb.)

Text and values on this page are quoted from Wikipedia (CC BY-SA 4.0), PubChem (public domain). Each value links to the exact revision it came from.